Publisher: Elsevier

Related content
Volume 149, Number 1, January 1998

< previous issue | all issues | next issue >

Favourites:Add to Favourites

An overview of current vaccine development
pp. 11-13(3)
Author: Plotkin, S.

Favourites:Add to Favourites

Adjuvants for influenza vaccine
pp. 19-23(5)
Authors: Le Cam, N.N.B.; Ronco, J.; Francon, A.; Blondeau, C.; Fanget, B.

Favourites:Add to Favourites

New prospects for mucosal immunization: anti-infectious and anti-inflammatory vaccines
pp. 29-31(3)
Authors: Holmgren, J.; Bergqvist, C.; Backstrom, M.; Czerkinsky, C.; Fredriksson, M.; Johansson, E.; Lebens, M.; Lindblad, M.; Mielcarek, N.; Rask, C.; Rudin, A.; Sun, J.

Favourites:Add to Favourites

Interleukin 12 as vaccine adjuvant
pp. 37-39(3)
Authors: Sturmhoefel, K.; Lee, K.; O Toole, M.; Swiniarski, H.M.; Dorner, A.J.; Wolf, S.F.

Favourites:Add to Favourites

T cells and vaccination
pp. 41-43(3)
Authors: Kourilsky, P.; Bousso, P.; Calbo, S.; Gapin, L.; Levraud, J.

Favourites:Add to Favourites
Favourites:Add to Favourites

Polymeric systems for vaccine delivery
pp. 49-52(4)
Author: Davis, S.S.

Favourites:Add to Favourites

The potential of lipid-modified peptides as synthetic vaccines, or for intracellular delivery of functional motifs
pp. 53-54(2)
Authors: Gras-Masse, H.; Tartar, A.; Druilhe, P.; Guillet, J.; Auriault, C.

Favourites:Add to Favourites

On the potential of retro-inverso peptides in vaccine design
pp. 55-57(3)
Authors: Muller, S.; Briand, J.P.

Favourites:Add to Favourites

DNA vaccines: immunogenicity, mechanisms, and preclinical efficacy
pp. 59-62(4)
Authors: Donnelly, J.J.; Liu, M.A.

Favourites:Add to Favourites

Immunostimulatory DNA sequences modulate T helper cell response
pp. 63-65(3)
Authors: Kobayashi, H.; Tighe, H.; Raz, E.

Favourites:Add to Favourites

New non-replicative vectors for CTL activation
pp. 67-69(3)
Authors: Leclerc, C.; Fayolle, C.; Guermonprez, P.; Ladant, D.; Lo-Man, R.; Rueda, P.; Sarraseca, J.; Saron, M.F.; Sebo, P.; Sedlik, C.; Casal, I.; Ullmann, A.

Favourites:Add to Favourites

Subunit vaccines produced and delivered in transgenic plants as ?edible vaccines?
pp. 71-74(4)
Authors: Mason, H.S.; Tacket, C.O.; Richter, L.J.; Arntzen, C.J.

Favourites:Add to Favourites

Peptide mimicry of carbohydrate structures
pp. 75-77(3)
Authors: Phalipon, A.; Folgori, A.; Arondel, J.; Sgaramella, G.; Fortugno, P.; Cortese, R.; Sansonetti, P.J.; Felici, F.

Favourites:Add to Favourites
Favourites:Add to Favourites

Recombinant Salmonella as vaccine carriers
pp. 87-90(4)
Authors: Kraehenbuhl, J.P.; Hopkins, S.; Corthesy-Theulaz, I.; Nardelli-Haefliger, D.

Favourites:Add to Favourites

Synthesis and antiviral activity of foot-and-mouth disease virus (FMDV) VPI fragments
pp. 91-91(1)
Authors: Rybakov, S.S.; Belyeva, N.V.; Petrov, V.N.

Favourites:Add to Favourites

Use of Gram-positive bacteria as vaccine vectors
pp. 92-93(2)
Author: Hruby, D.E.

Favourites:Add to Favourites
Favourites:Add to Favourites

Recombinant rotavirus outer capsid protein as a subunit vaccine
pp. 93-94(2)
Authors: Kang, D.K.; Kim, P.; Ko, E.; Seong, S.Y.; Kim, Y.H.; Kwon, I.C.; Jeong, S.Y.; Yang, J.M.

Favourites:Add to Favourites

Towards a DNA vaccine for bovine tuberculosis
pp. 94-95(2)
Authors: Chambers, M.; Commander, N.; Ellis, M.; Stagg, D.; Tascon, R.; Colston, M.J.; Lowrie, D.; Hewinson, R.G.

Favourites:Add to Favourites

Mycobacterial lipoproteins as vaccine candidates for DNA and subunit vaccines against tuberculosis
pp. 94-94(1)
Authors: Vordermeier, M.; Zhu, X.; Venkataprasad, V.; Ivanyi, J.

Favourites:Add to Favourites

Induction of allograft rejection in tolerant animals by specific T-cell DNA vaccination
pp. 95-96(2)
Authors: Vignes, C.; Douillard, P.; Soulillou, J.P.; Cuturi, M.C.

Favourites:Add to Favourites

The Bordetella pertussis filamentous haemagglutinin enhances immunogenicity of Sm28GST in liposomes
pp. 95-95(1)
Authors: Poulain-Godefroy, O.; Mielcarek, N.; Ivanoff, N.; Remoue, F.; Schacht, A.; Locht, C.; Capron, A.; Riveau, G.

Favourites:Add to Favourites

Delivery of recombinant adenylate cyclase of Bordetella pertussis carrying a foreign epitope in the MHC class I processing pathway
pp. 96-96(1)
Authors: Guermonprez, P.; Ladant, D.; Karimova, G.; Ullmann, A.; Leclerc, C.

Favourites:Add to Favourites

Whole virus influenza vaccine activates dendritic cells and promotes T helper-1 activity, while subunit vaccines stimulate T-cell proliferation
pp. 97-97(1)
Authors: Saurwein-Teissl, M.; Zisterer, K.; Schmitt, T.L.; Gluck, R.; Cryz, S.; Grubeck-Loebenstein, B.

Favourites:Add to Favourites
Favourites:Add to Favourites

RAP-PCR as a means of determining vaccine leads in mycobacteria
pp. 98-99(2)
Authors: Bedwell, J.; Kairo, S.; Tyler, P.

Favourites:Add to Favourites

A novel mucosal influenza vaccine
pp. 98-98(1)
Authors: Bacon, A.; Makin, J.; Chatfield, N.

Favourites:Add to Favourites

P40: a promising new carrier protein
pp. 99-99(1)
Authors: Rauly, I.; Goestch, L.; Libon, C.; Beck, A.; Haeuw, J.F.; Guyen, T.N.; Baussant, T.; Bonnefoy, J.Y.; Corvaia, N.

Favourites:Add to Favourites

Factors determining antibody isotype in measles virus DNA vaccination
pp. 99-100(2)
Authors: Cardoso, I.; Sixt, N.; Vallier, A.; Fayolle, J.; Buckland, R.; Wild, T.

Favourites:Add to Favourites

Experimental mucosal immunization against a widespread bacterial antigen: phosphorylcholine loaded in microspheres protects mice against pneumococcal pneumonia
pp. 100-100(1)
Authors: Trolle, S.; Chachaty, E.; Fattal, E.; Couvreur, P.; Alonso, J.M.; Andremont, A.

Favourites:Add to Favourites
Favourites:Add to Favourites

Recombinant Mycobacterium bovis BCG producing the N-terminal half of SIV mac251 Env antigen induces neutralizing antibodies and CTL responses in mice guinea pigs
pp. 101-101(1)
Authors: Lim, E.M.; Lagranderie, M.; Le Grand, R.; Rauzier, J.; Gheorghiu, M.; Gicquel, B.; Winter, N.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more